Home Apomorphine Infusion Shows Faster Parkinson's Gains.
Home initiation of under-the-skin (subcutaneous) apomorphine infusion for Parkinson's disease patients is faster at improving their quality of life than hospital initiation, according to a French study. The study found that home initiation of continuous subcutaneous apomorphine infusion (CSAI) is feasible and has the same efficacy and level of tolerance as in-hospital initiation. The treatment is used to treat motor fluctuations and can be administered via subcutaneous injections. The study included 145 patients, and after six months of treatment, there was an improvement in patients' reported quality of life by 21% in the whole group of patients and by 32% in the home group.